Vitamin C & Pancreatic Cancer: A Powerful Connection 🍊

A recent Phase II clinical trial revealed the potential of high-dose IV Vitamin C in improving outcomes for pancreatic cancer patients.

📊 The Study:

* Standard chemo (Gemcitabine + Abraxane) was paired with IV Vitamin C (75g, 3x/week).

* Goal: Plasma ascorbic acid levels of 20mM (350 mg/dL).

📈 The Results:

* Overall Survival: Doubled from 8 months (chemo only) to 16 months (with Vitamin C).

* Progression-Free Survival: Increased from 4 to 6 months in the Vitamin C group.

💡 What This Means:

Integrative therapies like high-dose Vitamin C are changing the game for cancer care. At Pre-Scribed.com, we dive deep into how these therapies can complement conventional treatments and improve outcomes.

👉 Explore more about integrative oncology and how to empower your cancer journey. Visit our website and listen to the Pre-Scribed Podcast by Dr. Nathan Goodyear for cutting-edge insights.

Supporting Evidence:
* Bodeker KL, Smith BJ, Berg DJ, Chandrasekharan C, Sharif S, Fei N, Vollstedt S, Brown H, Chandler M, Lorack A, McMichael S, Wulfekuhle J, Wagner BA, Buettner GR, Allen BG, Caster JM, Dion B, Kamgar M, Buatti JM, Cullen JJ. A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer. Redox Biol. 2024 Nov;77:103375. doi: 10.1016/j.redox.2024.103375.

#PancreaticCancerAwareness #IVVitaminC #CancerBreakthrough #IntegrativeOncology #PreScribed #VitaminCTherapy #CancerCare #HealthInnovation #HealingJourney #CancerResearch #HolisticHealth #SurvivorshipMatters